Suppr超能文献

可溶性 LDL 受体受 TNF-α诱导,抑制肝细胞清除 LDL 胆固醇。

Soluble LDL-receptor is induced by TNF-α and inhibits hepatocytic clearance of LDL-cholesterol.

机构信息

Cardiovascular Research Centre, School of Medical Sciences, Örebro University Södra Grev, Rosengatan 32, 703 62, Örebro, Sweden.

Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

出版信息

J Mol Med (Berl). 2023 Dec;101(12):1615-1626. doi: 10.1007/s00109-023-02379-4. Epub 2023 Oct 20.

Abstract

Defective LDL-C clearance and hence its elevation in the circulation is an established risk factor for cardiovascular diseases (CVDs) such as myocardial infarction (MI). A soluble LDL-receptor (sLDL-R) has been detected in human plasma which correlates strongly with circulating LDL-C and classical conditions that promote chronic inflammation. However, the mechanistic interplay between sLDL-R, inflammation, and CVDs remains to be investigated. Here, we report that stimulation of HepG2 cells with TNF-α induces the release of sLDL-R into culture supernatants. In addition, TNF-α induces gene expression of peptidases ADAM-17 and MMP-14 in HepG2 cells, and inhibiting these peptidases using TMI 1 significantly reduces the TNF-α induced sLDL-R release. We found that a soluble form of recombinant LDL-R (100 nM) can strongly bind to LDL-C and form a stable complex (KD = E-12). Moreover, incubation of HepG2 cells with this recombinant LDL-R resulted in reduced LDL-C uptake in a dose-dependent manner. In a nested case-control study, we found that baseline sLDL-R in plasma is positively correlated with plasma total cholesterol level. Furthermore, a twofold increase in plasma sLDL-R was associated with a 55% increase in the risk of future MI [AOR = 1.55 (95% CI = 1.10-2.18)]. Nevertheless, mediation analyses revealed that a significant proportion of the association is mediated by elevation in plasma cholesterol level (indirect effect β = 0.21 (95% CI = 0.07-0.38). Collectively, our study shows that sLDL-R is induced by a pro-inflammatory cytokine TNF-α via membrane shedding. Furthermore, an increase in sLDL-R could inhibit hepatic clearance of LDL-C increasing its half-life in the circulation and contributing to the pathogenesis of MI. KEY MESSAGES: TNF-α causes shedding of hepatocytic LDL-R through induction of ADAM-17 and MMP-14. sLDL-R binds strongly to LDL-C and inhibits its uptake by hepatocytic cells. Plasma sLDL-R is positively correlated with TNF-α and cholesterol. Plasma sLDL-R is an independent predictor of myocardial infarction (MI). Plasma cholesterol mediates the association between sLDL-R and MI.

摘要

LDL-C 清除缺陷导致其在循环中升高是心血管疾病(CVDs)如心肌梗死(MI)的既定风险因素。在人类血浆中已经检测到一种可溶性 LDL 受体(sLDL-R),它与循环 LDL-C 以及促进慢性炎症的经典条件密切相关。然而,sLDL-R、炎症和 CVDs 之间的机制相互作用仍有待研究。在这里,我们报告 TNF-α刺激 HepG2 细胞会诱导 sLDL-R 释放到培养上清液中。此外,TNF-α诱导 HepG2 细胞中肽酶 ADAM-17 和 MMP-14 的基因表达,并且使用 TMI 1 抑制这些肽酶可显著减少 TNF-α诱导的 sLDL-R 释放。我们发现,可溶性形式的重组 LDL-R(100 nM)可以强烈结合 LDL-C 并形成稳定的复合物(KD = E-12)。此外,重组 LDL-R 孵育 HepG2 细胞可导致 LDL-C 摄取呈剂量依赖性降低。在巢式病例对照研究中,我们发现血浆中 sLDL-R 的基线水平与血浆总胆固醇水平呈正相关。此外,血浆 sLDL-R 增加两倍与未来 MI 风险增加 55%相关 [AOR = 1.55(95%CI = 1.10-2.18)]。然而,中介分析显示,这种关联的很大一部分是由血浆胆固醇水平升高介导的(间接效应β= 0.21(95%CI = 0.07-0.38)。总之,我们的研究表明,sLDL-R 是由促炎细胞因子 TNF-α通过膜脱落诱导的。此外,sLDL-R 的增加可能会抑制肝脏对 LDL-C 的清除,从而增加其在循环中的半衰期,并导致 MI 的发病机制。主要发现:TNF-α通过诱导 ADAM-17 和 MMP-14 导致肝细胞 LDL-R 脱落。sLDL-R 与 LDL-C 强烈结合,并抑制肝细胞摄取 LDL-C。血浆 sLDL-R 与 TNF-α和胆固醇呈正相关。血浆 sLDL-R 是心肌梗死(MI)的独立预测因子。血浆胆固醇介导 sLDL-R 与 MI 之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21fa/10697900/294532bdf778/109_2023_2379_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验